Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1259/0007-1285-61-724-333 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Vascular Anatomy in Congenital Lung Lesions-Description and Classification.
Front Pediatr
May 2022
Competence Center for Pediatric Radiology, Kepler University Hospital, Linz, Austria.
Background: Bronchopulmonary sequestration (BPS) and hybrid lesion of congenital pulmonary airway malformation (CPAM) are congenital lung lesions typically presenting with systemic vascular connection. We describe and categorize this atypical systemic vascular anatomy in congenital lung lesions.
Methods: In a medical chart review from 2005 to 2020 patients with systemic vascular connection of congenital lung lesions were identified.
Case Report: Inferior Vena Cava Agenesia in a Young Male Patient Presenting With Bilateral Iliac Veins Thrombosis.
Front Surg
March 2022
Department of Vascular Surgery, University of Siena, Siena, Italy.
Introduction: Anomalies in inferior vena cava represent an uncommon finding with a prevalence of 0. 3 to 0.5% among healthy patients.
View Article and Find Full Text PDFPolysplenia syndrome and sickle cell trait: extensive deep venous thrombosis from venous stasis and hypercoagulability.
Clin Imaging
February 2022
Department of Radiological Sciences, University of California Los Angeles, Los Angeles, CA, USA.
Deep venous thrombosis is a hitherto under-recognized complication occurring in patients with polysplenia syndrome, despite the high prevalence of venous anomalies such as interrupted inferior vena cava (IVC) with azygos/hemiazygos continuation. Here we report the first case of concurrent polysplenia (as evidenced by interrupted IVC with azygos/hemiazygos continuation, multiple left-sided spleens, bowel malrotation with inverted mesenteric veins, preduodenal portal vein, and pancreatic hypoplasia/partial agenesis of the dorsal pancreas) and sickle cell trait, complicated by extensive deep venous thrombosis refractory to medical and interventional radiologic management.
View Article and Find Full Text PDFPentadecapeptide BPC 157 resolves suprahepatic occlusion of the inferior caval vein, Budd-Chiari syndrome model in rats.
World J Gastrointest Pathophysiol
March 2020
Departments of Pharmacology and Pathology, Medical Faculty University of Zagreb, Zagreb 10000, Croatia.
Background: Recently, as a possible therapy resolving solution, pentadecapeptide BPC 157 therapy, has been used in alleviating various vascular occlusion disturbances. BPC 157 was previously reviewed as novel mediator of Robert cytoprotection and endothelium protection in the stomach, and gut-brain axis, beneficial therapy in gastrointestinal tract, with particular reference to vascular recruitment, ulcerative colitis and tumor cachexia, and other tissues healing. Here we raised new hypothesis about BPC 157 therapy in the Budd-Chiari syndrome in rats, rapid bypassing of the suprahepatic inferior caval vein occlusion, and rats recovery with the active and effective pharmacotherapy treatment.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!